Rituximab or Zevalin - Efficacy Trial of Therapeutic Alternatives (RoZetta)
Clinical trial NCT01662102 · TERMINATED
Trial details
- NCT number
- NCT01662102
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-11
- Primary completion
- 2013-03-05
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.